These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12196028)

  • 1. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro.
    Czernik PJ; Peterson CA; Hurlburt BK
    J Biol Chem; 1996 Apr; 271(15):9141-9. PubMed ID: 8621566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.
    Lenormand JL; Benayoun B; Guillier M; Vandromme M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1997 Feb; 17(2):584-93. PubMed ID: 9001211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding of quadruplex structures of muscle-specific genes regulatory sequences by MyoD, MRF4 and myogenin.
    Yafe A; Shklover J; Weisman-Shomer P; Bengal E; Fry M
    Nucleic Acids Res; 2008 Jul; 36(12):3916-25. PubMed ID: 18511462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding.
    Chakraborty T; Brennan T; Olson E
    J Biol Chem; 1991 Feb; 266(5):2878-82. PubMed ID: 1847137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD.
    Kong Y; Flick MJ; Kudla AJ; Konieczny SF
    Mol Cell Biol; 1997 Aug; 17(8):4750-60. PubMed ID: 9234731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-mediated folding and assembly of MyoD-E47 heterodimers.
    Wendt H; Thomas RM; Ellenberger T
    J Biol Chem; 1998 Mar; 273(10):5735-43. PubMed ID: 9488706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interactions of Id proteins with basic-helix-loop-helix transcription factors.
    Langlands K; Yin X; Anand G; Prochownik EV
    J Biol Chem; 1997 Aug; 272(32):19785-93. PubMed ID: 9242638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements.
    Weintraub H; Genetta T; Kadesch T
    Genes Dev; 1994 Sep; 8(18):2203-11. PubMed ID: 7958889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E12 inhibitory domain prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors.
    Shirakata M; Paterson BM
    EMBO J; 1995 Apr; 14(8):1766-72. PubMed ID: 7737127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
    Olson E
    Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression and purification of MyoD, myogenin, and E12.
    Maleki SJ; Hurlburt BK
    Protein Expr Purif; 1997 Feb; 9(1):91-9. PubMed ID: 9116507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues.
    Shirakata M; Friedman FK; Wei Q; Paterson BM
    Genes Dev; 1993 Dec; 7(12A):2456-70. PubMed ID: 8253390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter.
    French BA; Chow KL; Olson EN; Schwartz RJ
    Mol Cell Biol; 1991 May; 11(5):2439-50. PubMed ID: 1850096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene.
    Catala F; Wanner R; Barton P; Cohen A; Wright W; Buckingham M
    Mol Cell Biol; 1995 Aug; 15(8):4585-96. PubMed ID: 7623850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression.
    Li L; Chambard JC; Karin M; Olson EN
    Genes Dev; 1992 Apr; 6(4):676-89. PubMed ID: 1313772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle.
    Parmacek MS; Ip HS; Jung F; Shen T; Martin JF; Vora AJ; Olson EN; Leiden JM
    Mol Cell Biol; 1994 Mar; 14(3):1870-85. PubMed ID: 8114720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.